Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: A randomised open trial

Psychiatry Research

Volumn 177, Issue 1-2, 2010, Pages 109-113

  Scharnholz, Barbara ^a   Weber Hamann, Bettina ^b   Lederbogen, Florian ^a   Schilling, Claudia ^a   Gilles, Maria ^a   Onken, Vera ^a   Frankhauser, Pascal ^c   Kopf, Daniel ^d   Deuschle, Michael ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Center for Psychiatry   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Antidepressants; Depression; HPA system; Psychopharmacology; Remission; Response

Indexed keywords

HYDROCORTISONE; LORAZEPAM; MIRTAZAPINE; VENLAFAXINE; ZOLPIDEM;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG RESPONSE; EVENING DOSAGE; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SALIVA LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; CIRCADIAN RHYTHM; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIANSERIN; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SALIVA; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952090273     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2009.08.010     Document Type: Article

References (21)

1. Araya A.V., Rojas P., Fritsch R., Rojas R., Herrera L., Rojas G., Gatica H., Silva H., Fiedler J.L. Early response to venlafaxine antidepressant correlates with lower ACTH levels prior to pharmacological treatment. Endocrine 2006, 30:289-298.
2. Brown E.S., Varghese F.P., McEwen B.S. Association of depression with medical illness: does cortisol play a role?. Biological Psychiatry 2004, 55:1-9.
3. Bschorr T., Baethge C., Adli M., Eichmann U., Ising M., Uhr M., Müller-Oerlinghausen B., Bauer M. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Depression and Anxiety 2003, 17:43-48.
4. Deuschle M., Schweiger U., Gotthardt U., Weber B., Körner A., Schmider J., Standhardt H., Lammers C.H., Krumm B., Heuser I. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamus-pituitary-adrenocortical system than the dexamethasone suppression test. Biological Psychiatry 1998, 43:762-766.
5. Deuschle M., Hamann B., Meichel C., Krumm B., Lederbogen F., Kniest A., Colla M., Heuser I. Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. Journal of Clinical Psychopharmacology 2003, 23:201-205.
6. Heuser I., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., Holsboer F. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. The American Journal of Psychiatry 1996, 153:93-99.
7. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477-501.
8. Horstmann S., Dose T., Lucae S., Kloiber S., Menke A., Hennings J., Spieler D., Uhr M., Holsboer F., Ising M. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action. Psychoneuroendocrinology 2009, 34:238-248.
9. Kahl K.G., Rudolf S., Stöckelhuber B.M., Dibbelt L., Gehl H.B., Markhof K., Hohagen F., Schweiger U. Bone mineral density, markers of bone turnover and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. The American Journal of Psychiatry 2005, 162:168-174.
10. Marx C., Ehrhart-Bornstein M., Scherbaum W.A., Bornstein S.R. Regulation of adrenocortical function by cytokines-relevance for immune-endocrine interaction. Hormone and metabolic research. Hormon- und Stoffwechselforschung. Hormones et Métabolisme 1998, 30:416-420.
11. Modell S., Yassouridis A., Huber J., Holsboer F. Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 1997, 65:216-222.
12. Müller M.B., Holsboer F. Mice with mutations in the HPA-system as models for symptoms of depression. Biological Psychiatry 2006, 59:1104-1115.
13. Nikisch G., Mathe A.A., Czernik A., Thiele J., Bohner J., Eap C.B., Agren H., Baumann P. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid and clinical response. Psychopharmacology 2005, 181:751-760.
14. Schmid D.A., Wichniak A., Uhr M., Ising M., Brunner H., Held K., Weikel J.C., Sonntag A., Steiger A. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal ACTH, GH, prolactin, melatonin, ghrelin and leptin and the DEX/CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology 2006, 31:832-844.
15. Schüle C. Neuroendocrinological mechanisms of actions of antidepressant drugs. Journal of Neuroendocrinology 2006, 19:213-226.
16. Schüle C., Baghai T., Eser D., Zwanzger P., Jordan M., Buechs R., Rupprecht R. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. Psychopharmacology 2006, 186:601-611.
17. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology 1992, 55:621-626.
18. Szafarczyk A., Malaval F., Laurent A., Gibaud R., Assenmacher I. Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinology 1987, 121:883-892.
19. Weber-Hamann B., Hentschel F., Kniest A., Deuschle M., Colla M., Lederbogen F., Heuser I. Hypercortisolemic depression is associated with increased intra-abdominal fat. Psychosomatic Medicine 2002, 64:274-277.
20. Weber-Hamann B., Kopf D., Lederbogen F., Gilles M., Heuser I., Colla M., Deuschle M. Activity of the hypothalamus-pituitary-adrenal system and oral glucose tolerance in depressed patients. Neuroendocrinology 2005, 81:200-204.
21. Zobel A.W., Nickel T., Sonntag A., Uhr M., Holsboer F., Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. Journal of Psychiatric Research 2001, 35:83-94.